Literature DB >> 5706569

[Studies of blood coagulation disorders following thoracic surgery. A contribution to the problem of postoperative thrombosis and embolism impendence].

D Wülfing, H Egli, H Kalinke.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5706569     DOI: 10.1007/bf01444959

Source DB:  PubMed          Journal:  Langenbecks Arch Chir        ISSN: 0023-8236


× No keyword cloud information.
  27 in total

1.  [Post-operative thrombophilia in thoracic surgery (excluding heart surgery) studied by thromboelastography].

Authors:  J P WITZ; P REYS; G DE HAYNIN; A G WEISS
Journal:  Poumon Coeur       Date:  1959-04

2.  [Thrombo-embolic complications in thoracic surgery (excluding the heart & esophagus); statistics on 1525 surgical cases].

Authors:  J P WITZ; P REYS; A G WEISS
Journal:  Poumon Coeur       Date:  1959-04

Review 3.  PATHOLOGICAL FIBRINOLYSIS.

Authors:  A A SHARP
Journal:  Br Med Bull       Date:  1964-09       Impact factor: 4.291

4.  Changes in the coagulation system following major surgical operations.

Authors:  O EGEBERG
Journal:  Acta Med Scand       Date:  1962-06

5.  Spontaneous anticoagulants in surgery.

Authors:  K N VON KAULLA
Journal:  Acta Haematol       Date:  1960 Jul-Sep       Impact factor: 2.195

6.  [Diffuse bleeding as cause of death in thoracic surgery].

Authors:  K L SCHOBER; I HORNING
Journal:  Bruns Beitr Klin Chir       Date:  1958

7.  The effect of stored blood transfusions on the platelet levels in patients undergoing surgical procedures.

Authors:  J F MUSTARD
Journal:  Acta Haematol       Date:  1957-07       Impact factor: 2.195

8.  The fibrinolytic activity of the human endometrium.

Authors:  O K ALBRECHTSEN
Journal:  Acta Endocrinol (Copenh)       Date:  1956-10

9.  Postoperative thrombophilia.

Authors:  R WARREN
Journal:  N Engl J Med       Date:  1953-07-16       Impact factor: 91.245

10.  Experiments on a new clotting factor (factor VII).

Authors:  F KOLLER; A LOELIGER; F DUCKERT
Journal:  Acta Haematol       Date:  1951       Impact factor: 2.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.